Pfizer MVC 300 (Selzentry 300 mg)
Generic Name: maraviroc
Pill imprint Pfizer MVC 300 has been identified as Selzentry 300 mg.
Selzentry is used in the treatment of hiv infection and belongs to the drug class chemokine receptor antagonist. There is no proven risk in humans during pregnancy. Selzentry 300 mg is not a controlled substance under the Controlled Substance Act (CSA).
Selzentry
- Generic Name:
- maraviroc
- Imprint:
- Pfizer MVC 300
- Strength:
- 300 mg
- Color:
- Blue
- Size:
- 12.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Chemokine receptor antagonist
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Pfizer U.S. Pharmaceuticals Group
- National Drug Code (NDC):
- 00069-0808
- Inactive Ingredients:
- microcrystalline cellulose
calcium phosphate dibasic anhydrous
sodium starch glycolate type A potato
magnesium stearate
FD&C Blue No. 2
aluminum oxide
soya lecithin
polyethylene glycol
polyvinyl alcohol
magnesium silicate
titanium dioxide
More about Selzentry (maraviroc)
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
